TrialThe lancet. HIV2026

Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial.

Jayne Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.